<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Ubiquitination in Plasmodium — Project 2</title>
  <style>
    *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }

    body {
      font-family: 'Georgia', serif;
      background: #f8f7f4;
      color: #2c2c2c;
      line-height: 1.75;
    }

    /* ── Navigation ── */
    nav {
      background: #fff;
      border-bottom: 1px solid #e4e0d8;
      padding: 0 2.5rem;
      display: flex;
      align-items: center;
      justify-content: space-between;
      height: 58px;
      position: sticky;
      top: 0;
      z-index: 100;
    }
    nav .brand {
      font-size: 0.9rem;
      font-family: 'Helvetica Neue', sans-serif;
      font-weight: 600;
      letter-spacing: 0.08em;
      text-transform: uppercase;
      color: #3a3a3a;
    }
    nav ul {
      list-style: none;
      display: flex;
      gap: 2rem;
    }
    nav ul a {
      text-decoration: none;
      font-family: 'Helvetica Neue', sans-serif;
      font-size: 0.82rem;
      letter-spacing: 0.04em;
      color: #666;
      transition: color 0.2s;
    }
    nav ul a:hover { color: #2c2c2c; }

    /* ── Hero ── */
    .hero {
      background: #fff;
      border-bottom: 1px solid #e4e0d8;
      padding: 5rem 2.5rem 4rem;
      text-align: center;
    }
    .hero .tag {
      display: inline-block;
      font-family: 'Helvetica Neue', sans-serif;
      font-size: 0.72rem;
      letter-spacing: 0.14em;
      text-transform: uppercase;
      color: #8c7b5e;
      border: 1px solid #d4c9b0;
      padding: 0.3rem 0.8rem;
      border-radius: 2px;
      margin-bottom: 1.5rem;
    }
    .hero h1 {
      font-size: clamp(1.8rem, 4vw, 2.8rem);
      font-weight: normal;
      color: #1a1a1a;
      max-width: 720px;
      margin: 0 auto 1rem;
      letter-spacing: -0.01em;
    }
    .hero p {
      font-size: 1.05rem;
      color: #666;
      max-width: 560px;
      margin: 0 auto;
      font-family: 'Helvetica Neue', sans-serif;
    }

    /* ── Layout ── */
    .container {
      max-width: 900px;
      margin: 0 auto;
      padding: 0 2rem;
    }

    section {
      padding: 4rem 0;
      border-bottom: 1px solid #e4e0d8;
    }
    section:last-of-type { border-bottom: none; }

    .section-label {
      font-family: 'Helvetica Neue', sans-serif;
      font-size: 0.7rem;
      letter-spacing: 0.16em;
      text-transform: uppercase;
      color: #8c7b5e;
      margin-bottom: 1.5rem;
    }

    h2 {
      font-size: 1.55rem;
      font-weight: normal;
      color: #1a1a1a;
      margin-bottom: 1.2rem;
      letter-spacing: -0.01em;
    }

    p { margin-bottom: 1rem; color: #444; font-size: 1rem; }
    p:last-child { margin-bottom: 0; }

    /* ── Stat cards ── */
    .stats {
      display: grid;
      grid-template-columns: repeat(3, 1fr);
      gap: 1px;
      background: #e4e0d8;
      border: 1px solid #e4e0d8;
      border-radius: 4px;
      overflow: hidden;
      margin-top: 2.5rem;
    }
    .stat {
      background: #fff;
      padding: 1.4rem 1.6rem;
      text-align: center;
    }
    .stat .num {
      font-size: 1.9rem;
      font-weight: 300;
      color: #1a1a1a;
      display: block;
      font-family: 'Helvetica Neue', sans-serif;
    }
    .stat .lbl {
      font-size: 0.75rem;
      color: #888;
      font-family: 'Helvetica Neue', sans-serif;
      letter-spacing: 0.04em;
      margin-top: 0.2rem;
      display: block;
    }

    /* ── Paper cards ── */
    .papers { display: flex; flex-direction: column; gap: 1.5rem; margin-top: 1rem; }

    .paper-card {
      background: #fff;
      border: 1px solid #e4e0d8;
      border-radius: 4px;
      padding: 1.8rem 2rem;
      transition: box-shadow 0.2s;
    }
    .paper-card:hover { box-shadow: 0 4px 18px rgba(0,0,0,0.06); }

    .paper-card .paper-meta {
      display: flex;
      align-items: center;
      gap: 0.8rem;
      margin-bottom: 0.7rem;
    }
    .paper-card .year {
      font-family: 'Helvetica Neue', sans-serif;
      font-size: 0.72rem;
      letter-spacing: 0.1em;
      color: #8c7b5e;
      background: #f5f0e8;
      padding: 0.2rem 0.55rem;
      border-radius: 2px;
    }
    .paper-card .source-tag {
      font-family: 'Helvetica Neue', sans-serif;
      font-size: 0.7rem;
      letter-spacing: 0.08em;
      color: #888;
      text-transform: uppercase;
    }

    .paper-card h3 {
      font-size: 1.05rem;
      font-weight: normal;
      color: #1a1a1a;
      margin-bottom: 0.75rem;
      line-height: 1.5;
    }

    .paper-card p {
      font-size: 0.92rem;
      color: #555;
      margin-bottom: 1.1rem;
    }

    .paper-card .paper-footer {
      display: flex;
      align-items: center;
      justify-content: space-between;
      flex-wrap: wrap;
      gap: 0.5rem;
    }
    .paper-card .doi {
      font-family: 'Helvetica Neue', sans-serif;
      font-size: 0.75rem;
      color: #999;
      letter-spacing: 0.02em;
    }
    .paper-card a.link-btn {
      font-family: 'Helvetica Neue', sans-serif;
      font-size: 0.75rem;
      text-decoration: none;
      color: #5a7a5a;
      border: 1px solid #b8cebc;
      padding: 0.3rem 0.9rem;
      border-radius: 2px;
      letter-spacing: 0.04em;
      transition: background 0.2s, color 0.2s;
    }
    .paper-card a.link-btn:hover { background: #5a7a5a; color: #fff; }

    /* ── Footer ── */
    footer {
      background: #fff;
      border-top: 1px solid #e4e0d8;
      text-align: center;
      padding: 2rem;
      font-family: 'Helvetica Neue', sans-serif;
      font-size: 0.78rem;
      color: #aaa;
      letter-spacing: 0.04em;
    }
  </style>
</head>
<body>

  <!-- Navigation -->
  <nav>
    <span class="brand">Project 2</span>
    <ul>
      <li><a href="#intro">Introduction</a></li>
      <li><a href="#research">Research Focus</a></li>
      <li><a href="#papers">Papers</a></li>
    </ul>
  </nav>

  <!-- Hero -->
  <div class="hero">
    <span class="tag">Literature Review</span>
    <h1>Ubiquitination in <em>Plasmodium falciparum</em></h1>
    <p>Exploring the ubiquitin–proteasome system as a regulatory mechanism and antimalarial drug target.</p>
  </div>

  <!-- Introduction -->
  <section id="intro">
    <div class="container">
      <p class="section-label">Introduction</p>
      <h2>About <em>Plasmodium falciparum</em></h2>
      <p>
        <em>Plasmodium falciparum</em> is the protozoan parasite responsible for the most severe form of human malaria.
        Transmitted through the bite of infected female <em>Anopheles</em> mosquitoes, it completes a complex life cycle
        spanning both the mosquito vector and the human host. Within humans, the parasite undergoes asexual replication
        inside red blood cells — progressing through ring, trophozoite, and schizont stages — before bursting out to
        infect new cells, causing the cyclical fevers characteristic of the disease.
      </p>
      <p>
        Malaria caused by <em>P. falciparum</em> remains one of the deadliest infectious diseases globally, claiming
        hundreds of thousands of lives each year, predominantly in sub-Saharan Africa. The parasite's ability to
        develop resistance to frontline antimalarials — including artemisinin-based combination therapies — makes the
        identification of new drug targets an urgent priority.
      </p>
      <p>
        At the molecular level, <em>P. falciparum</em> relies on tightly regulated post-translational modification
        pathways to orchestrate stage-specific proteome changes. Among these, the ubiquitin–proteasome system (UPS)
        has emerged as a central regulatory hub governing parasite development, stress responses, and drug
        susceptibility.
      </p>

      <div class="stats">
        <div class="stat">
          <span class="num">~600,000</span>
          <span class="lbl">Deaths per year globally</span>
        </div>
        <div class="stat">
          <span class="num">>100</span>
          <span class="lbl">UPS-related genes in <em>P. falciparum</em></span>
        </div>
        <div class="stat">
          <span class="num">4</span>
          <span class="lbl">Intraerythrocytic life cycle stages</span>
        </div>
      </div>
    </div>
  </section>

  <!-- Research Focus -->
  <section id="research">
    <div class="container">
      <p class="section-label">Research Focus</p>
      <h2>The Ubiquitin–Proteasome System in Malaria</h2>
      <p>
        Ubiquitination is a post-translational modification in which ubiquitin — a small, highly conserved protein —
        is covalently attached to target proteins. This modification can direct proteins to the proteasome for
        degradation, alter their activity, or regulate protein–protein interactions. The process is carried out by a
        cascade of enzymes: E1 activating enzymes, E2 conjugating enzymes, and E3 ubiquitin ligases that confer
        substrate specificity.
      </p>
      <p>
        In <em>P. falciparum</em>, the UPS is essential for survival. The parasite encodes multiple E1, E2, and E3
        enzymes, as well as deubiquitinating enzymes (DUBs) that reverse ubiquitin modifications. Disruption of
        key UPS components consistently impairs parasite growth and, in several cases, sensitises parasites to
        artemisinin — highlighting the UPS as both a biological regulator and a promising therapeutic vulnerability.
      </p>
    </div>
  </section>

  <!-- Papers -->
  <section id="papers">
    <div class="container">
      <p class="section-label">Key Literature</p>
      <h2>5 Selected Papers</h2>

      <div class="papers">

        <div class="paper-card">
          <div class="paper-meta">
            <span class="year">2023</span>
            <span class="source-tag">PubMed</span>
          </div>
          <h3>A <em>Plasmodium falciparum</em> RING Finger E3 Ubiquitin Ligase Modifies the Roles of PfMDR1 and PfCRT in Parasite Drug Responses</h3>
          <p>Knockdown of PfRFUL, a RING finger E3 ubiquitin ligase, rendered <em>P. falciparum</em> more sensitive to mefloquine, piperaquine, amodiaquine, and dihydroartemisinin. The study shows that ubiquitination directly regulates key drug transporter proteins PfMDR1 and PfCRT, linking the UPS to antimalarial drug resistance mechanisms.</p>
          <div class="paper-footer">
            <span class="doi">DOI: 10.1128/aac.00821-22</span>
            <a class="link-btn" href="https://pubmed.ncbi.nlm.nih.gov/36625569/" target="_blank" rel="noopener">View on PubMed</a>
          </div>
        </div>

        <div class="paper-card">
          <div class="paper-meta">
            <span class="year">2023</span>
            <span class="source-tag">PubMed</span>
          </div>
          <h3>Unusually Divergent Ubiquitin Genes and Proteins in <em>Plasmodium</em> Species</h3>
          <p>Ubiquitin — among the most conserved proteins in eukaryotes — has undergone unusually rapid sequence divergence in multiple <em>Plasmodium</em> lineages. The RPL40 and RPS27a fusion gene ubiquitins evolved independently in distinct subgenera, and polyubiquitin genes acquired novel codon insertions, revealing lineage-specific evolutionary pressures on the ubiquitin system in malaria parasites.</p>
          <div class="paper-footer">
            <span class="doi">DOI: 10.1093/gbe/evad137</span>
            <a class="link-btn" href="https://pubmed.ncbi.nlm.nih.gov/37481258/" target="_blank" rel="noopener">View on PubMed</a>
          </div>
        </div>

        <div class="paper-card">
          <div class="paper-meta">
            <span class="year">2017</span>
            <span class="source-tag">PubMed</span>
          </div>
          <h3>Lys48 Ubiquitination During the Intraerythrocytic Cycle of the Rodent Malaria Parasite, <em>Plasmodium chabaudi</em></h3>
          <p>This study maps Lys48-linked polyubiquitination — the canonical proteasomal degradation signal — across ring, trophozoite, and schizont stages of <em>P. chabaudi</em>. Ubiquitinated proteins peak at the schizont stage and correspond to proteins abundant in earlier trophozoite stages, demonstrating that the UPS coordinates protein turnover and cell-cycle progression throughout the intraerythrocytic cycle.</p>
          <div class="paper-footer">
            <span class="doi">DOI: 10.1371/journal.pone.0176533</span>
            <a class="link-btn" href="https://pubmed.ncbi.nlm.nih.gov/28604779/" target="_blank" rel="noopener">View on PubMed</a>
          </div>
        </div>

        <div class="paper-card">
          <div class="paper-meta">
            <span class="year">2023</span>
            <span class="source-tag">PubMed</span>
          </div>
          <h3>A <em>Plasmodium falciparum</em> Ubiquitin-Specific Protease (PfUSP) Is Essential for Parasite Survival and Its Disruption Enhances Artemisinin Efficacy</h3>
          <p>PfUSP, a deubiquitinating enzyme, is shown to be essential for <em>P. falciparum</em> growth and proteostasis. Knockdown significantly increased parasite sensitivity to dihydroartemisinin without affecting chloroquine susceptibility, indicating that PfUSP helps the parasite tolerate artemisinin-induced cellular stress and represents a target to overcome artemisinin resistance.</p>
          <div class="paper-footer">
            <span class="doi">DOI: 10.1042/BCJ20220429</span>
            <a class="link-btn" href="https://pubmed.ncbi.nlm.nih.gov/36511651/" target="_blank" rel="noopener">View on PubMed</a>
          </div>
        </div>

        <div class="paper-card">
          <div class="paper-meta">
            <span class="year">2024</span>
            <span class="source-tag">PubMed</span>
          </div>
          <h3><em>Plasmodium falciparum</em> Contains Functional SCF and CRL4 Ubiquitin E3 Ligases, and CRL4 Is Critical for Cell Division and Membrane Integrity</h3>
          <p>This study characterises two functional Cullin-RING E3 ligase complexes in <em>P. falciparum</em> — PfSCF (Cullin-1) and PfCRL4 (Cullin-2). Depletion of PfCullin-2 severely impaired asexual and sexual erythrocytic development and disrupted protein translation, lipid biosynthesis, and membrane integrity, establishing CRL4 as an essential regulator of parasite cell division and a potential drug target.</p>
          <div class="paper-footer">
            <span class="doi">DOI: 10.1371/journal.ppat.1012045</span>
            <a class="link-btn" href="https://pubmed.ncbi.nlm.nih.gov/38416790/" target="_blank" rel="noopener">View on PubMed</a>
          </div>
        </div>

      </div>
    </div>
  </section>

  <footer>
    Project 2 &mdash; Ubiquitination in <em>Plasmodium</em> &mdash; Literature Review
  </footer>

</body>
</html>
